BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28423499)

  • 1. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
    Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
    Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of imidazoline I
    Zhang W; Li X; Liu Y; Chen H; Gong J
    Biomed Pharmacother; 2017 Jun; 90():821-834. PubMed ID: 28437886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide riboside protects against liver fibrosis induced by CCl
    Jiang R; Zhou Y; Wang S; Pang N; Huang Y; Ye M; Wan T; Qiu Y; Pei L; Jiang X; Huang Y; Yang H; Ling W; Li X; Zhang Z; Yang L
    Life Sci; 2019 May; 225():20-28. PubMed ID: 30928408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Mechanisms of Propolis Against CCl
    Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
    Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
    Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelargonidin ameliorates CCl
    Shi YS; Li XX; Li HT; Zhang Y
    Food Funct; 2020 Jun; 11(6):5156-5165. PubMed ID: 32432601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling.
    Ge C; Tan J; Lou D; Zhu L; Zhong Z; Dai X; Sun Y; Kuang Q; Zhao J; Wang L; Liu J; Wang B; Xu M
    Redox Biol; 2022 May; 51():102274. PubMed ID: 35240537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisandrin B attenuates CCl
    Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
    Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
    Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
    Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
    J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
    Gong Y; Yang Y
    Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats.
    Li J; Hu R; Xu S; Li Y; Qin Y; Wu Q; Xiao Z
    Biomed Pharmacother; 2017 Dec; 96():847-853. PubMed ID: 29078262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.
    Xu P; Zhang Y; Liu Y; Yuan Q; Song L; Liu M; Liu Z; Yang Y; Li J; Li D; Ren G
    Toxicol Appl Pharmacol; 2016 Jan; 290():43-53. PubMed ID: 26592322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin mitigates carbon tetrachloride-induced TGF-β1/Smad3 signaling and liver fibrosis in mice.
    Fan K; Wu K; Lin L; Ge P; Dai J; He X; Hu K; Zhang L
    Biomed Pharmacother; 2017 Jun; 90():421-426. PubMed ID: 28390311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
    He J; Bai K; Hong B; Zhang F; Zheng S
    Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
    Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
    J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.